{"artifact":{"id":"experiment-exp-cd85e950-e169-432f-a651-510fdde03f01","artifact_type":"experiment","entity_ids":"[\"SNCA\"]","title":"Dexamethasone treatment study in α-synuclein mice","quality_score":0.85,"created_by":"experiment_extractor","provenance_chain":"[]","content_hash":"262e815c6d5885c76a883fd621cb6b87cb02e6cddc6167a5dd108fb6ad6818fc","metadata":{"_origin":{"url":null,"type":"internal","tracked_at":"2026-04-10T22:34:48.742785"},"p_value":null,"protocol":"Dexamethasone treatment for 1 month starting at 5 months of age, followed by assessment of brain microglia and wheel-running activity","effect_size":null,"sample_size":null,"source_pmid":"25522431","extracted_at":"2026-04-10T15:34:48.643961","_schema_version":1,"experiment_type":"animal_model","success_criteria":"Significant decrease in microglial response and functional recovery in motor tests","expected_outcomes":"Reduced microglial response and improved motor function","statistical_methods":null},"created_at":"2026-04-10T22:34:48-07:00","updated_at":"2026-04-10T22:34:48-07:00","version_number":4,"parent_version_id":null,"version_tag":null,"changelog":null,"is_latest":1,"lifecycle_state":"active","superseded_by":null,"deprecated_at":null,"deprecated_reason":null,"dependencies":null,"market_price":0.5,"origin_type":"internal","origin_url":null,"lifecycle_changed_at":"2026-04-10T22:34:48-07:00","citation_count":0,"embed_count":0,"derivation_count":0,"support_count":0,"contradiction_count":0,"total_usage":0.0,"usage_score":0.5,"usage_computed_at":null,"quality_status":"ok","contributors":[],"answers_question_ids":null,"deprecated_reason_detail":null,"deprecated_reason_code":null,"commit_sha":null,"commit_submodule":null,"last_mutated_at":"2026-05-16T14:51:34.657673-07:00","disputed_at":null,"gap_id":null,"mission_id":null,"intrinsic_priority":null,"effective_priority":null,"artifact_id":"29e2b75d-03ba-4527-a830-e902273c16e8","artifact_dir":null,"primary_filename":null,"accessory_filenames":null,"folder_layout_version":1,"migrated_to_folder_at":null,"hypothesis_id":null,"authorship":{"kind":"human","contributors":[{"role":"author","actor_ref":"experiment_extractor"}]},"epistemic_tier":"T3_provisional","created_by_agent_id":null},"outgoing_links":[{"target_artifact_id":"paper-25522431","link_type":"derives_from","strength":1.0,"evidence":"Extracted from paper abstract/full text"},{"target_artifact_id":"experiment-exp-e67da95a-fc6f-457a-9743-1cc6ea90e57f","link_type":"related","strength":1.0,"evidence":"Shared entity overlap (Jaccard=1.00)"},{"target_artifact_id":"experiment-exp-dbfdb26b-4a5f-463a-8a23-9e7dbdbe0d1a","link_type":"related","strength":1.0,"evidence":"Shared entity overlap (Jaccard=1.00)"},{"target_artifact_id":"experiment-exp-28e744bb-a65b-4b06-8636-82e5a2986207","link_type":"related","strength":1.0,"evidence":"Shared entity overlap (Jaccard=1.00)"},{"target_artifact_id":"wiki-mechanisms-snca-alpha-synuclein-lewy-bodies-causal-chain","link_type":"related","strength":0.7200000000000001,"evidence":"Reverse: Gene target: SNCA"},{"target_artifact_id":"wiki-diseases-snca-a53t","link_type":"related","strength":0.7200000000000001,"evidence":"Reverse: Gene target: SNCA"},{"target_artifact_id":"wiki-cell-types-snca-a53t-neurons","link_type":"related","strength":0.7200000000000001,"evidence":"Reverse: Gene target: SNCA"},{"target_artifact_id":"wiki-diseases-park19","link_type":"related","strength":0.54,"evidence":"Reverse: Disease match: parkinson's disease"},{"target_artifact_id":"wiki-genes-snca","link_type":"related","strength":0.7200000000000001,"evidence":"Reverse: Gene target: SNCA"},{"target_artifact_id":"wiki-diseases-parkinsons-subtypes","link_type":"related","strength":0.54,"evidence":"Reverse: Disease match: parkinson's disease"},{"target_artifact_id":"wiki-diseases-dementia-lewy-bodies-parkinsons","link_type":"related","strength":0.54,"evidence":"Reverse: Disease match: parkinson's disease"},{"target_artifact_id":"wiki-diseases-prodromal-parkinsons","link_type":"related","strength":0.54,"evidence":"Reverse: Disease match: parkinson's disease"},{"target_artifact_id":"wiki-diseases-parkinsons-disease-gut-first-vs-brain-first-trajectories","link_type":"related","strength":0.54,"evidence":"Reverse: Disease match: parkinson's disease"},{"target_artifact_id":"wiki-entities-snca","link_type":"related","strength":0.7200000000000001,"evidence":"Reverse: Gene target: SNCA"},{"target_artifact_id":"wiki-cell-types-microglia","link_type":"related","strength":0.54,"evidence":"Reverse: Title match: Microglia"},{"target_artifact_id":"wiki-diseases-snca-variants","link_type":"related","strength":0.7200000000000001,"evidence":"Reverse: Gene target: SNCA"},{"target_artifact_id":"wiki-proteins-snca-protein","link_type":"related","strength":0.7200000000000001,"evidence":"Reverse: Gene target: SNCA"},{"target_artifact_id":"wiki-diseases-dementia-lewy-bodies-parkinsons-alzheimers-comparison","link_type":"related","strength":0.54,"evidence":"Reverse: Disease match: parkinson's disease"},{"target_artifact_id":"wiki-cell-types-snca-overexpressing-dopaminergic-neurons","link_type":"related","strength":0.7200000000000001,"evidence":"Reverse: Gene target: SNCA"},{"target_artifact_id":"wiki-diseases-investment-landscape-parkinsons","link_type":"related","strength":0.54,"evidence":"Reverse: Disease match: parkinson's disease"},{"target_artifact_id":"wiki-diseases-alzheimers-parkinsons-comparison","link_type":"related","strength":0.54,"evidence":"Reverse: Disease match: parkinson's disease"},{"target_artifact_id":"wiki-diseases-parkinsons-disease","link_type":"related","strength":0.54,"evidence":"Reverse: Disease match: parkinson's disease"},{"target_artifact_id":"wiki-proteins-parkin","link_type":"related","strength":0.54,"evidence":"Reverse: Title match: Parkin"},{"target_artifact_id":"wiki-entities-microglia","link_type":"related","strength":0.54,"evidence":"Reverse: Title match: Microglia"},{"target_artifact_id":"wiki-mechanisms-snca-alpha-synuclein-pd-causal-chain","link_type":"related","strength":0.7200000000000001,"evidence":"Reverse: Gene target: SNCA"},{"target_artifact_id":"wiki-diseases-parkinsons-genetic-variants","link_type":"related","strength":0.54,"evidence":"Reverse: Disease match: parkinson's disease"},{"target_artifact_id":"wiki-diseases-parkinsons-disease-dementia","link_type":"related","strength":0.54,"evidence":"Reverse: Disease match: parkinson's disease"},{"target_artifact_id":"wiki-diseases-atp13a9-pd","link_type":"related","strength":0.54,"evidence":"Reverse: Disease match: parkinson's disease"},{"target_artifact_id":"wiki-diseases-caregiver-support-palliative-care-cbs-psp","link_type":"related","strength":0.54,"evidence":"Reverse: Disease match: parkinson's disease"},{"target_artifact_id":"wiki-mechanisms-nct04724941-prodromal-alpha-synuclein-screening","link_type":"mentions","strength":0.9,"evidence":"target_gene: SNCA"},{"target_artifact_id":"wiki-depression","link_type":"related","strength":0.7,"evidence":"disease: Parkinson's disease"}],"incoming_links":[{"source_artifact_id":"experiment-exp-e67da95a-fc6f-457a-9743-1cc6ea90e57f","link_type":"related","strength":1.0,"evidence":"Shared entity overlap (Jaccard=1.00)"},{"source_artifact_id":"experiment-exp-dbfdb26b-4a5f-463a-8a23-9e7dbdbe0d1a","link_type":"related","strength":1.0,"evidence":"Shared entity overlap (Jaccard=1.00)"},{"source_artifact_id":"experiment-exp-28e744bb-a65b-4b06-8636-82e5a2986207","link_type":"related","strength":1.0,"evidence":"Shared entity overlap (Jaccard=1.00)"},{"source_artifact_id":"wiki-mechanisms-snca-alpha-synuclein-lewy-bodies-causal-chain","link_type":"mentions","strength":0.8,"evidence":"Gene target: SNCA"},{"source_artifact_id":"wiki-diseases-snca-a53t","link_type":"mentions","strength":0.8,"evidence":"Gene target: SNCA"},{"source_artifact_id":"wiki-cell-types-snca-a53t-neurons","link_type":"mentions","strength":0.8,"evidence":"Gene target: SNCA"},{"source_artifact_id":"wiki-diseases-park19","link_type":"mentions","strength":0.6,"evidence":"Disease match: parkinson's disease"},{"source_artifact_id":"wiki-genes-snca","link_type":"mentions","strength":0.8,"evidence":"Gene target: SNCA"},{"source_artifact_id":"wiki-diseases-parkinsons-subtypes","link_type":"mentions","strength":0.6,"evidence":"Disease match: parkinson's disease"},{"source_artifact_id":"wiki-diseases-dementia-lewy-bodies-parkinsons","link_type":"mentions","strength":0.6,"evidence":"Disease match: parkinson's disease"},{"source_artifact_id":"wiki-diseases-prodromal-parkinsons","link_type":"mentions","strength":0.6,"evidence":"Disease match: parkinson's disease"},{"source_artifact_id":"wiki-diseases-parkinsons-disease-gut-first-vs-brain-first-trajectories","link_type":"mentions","strength":0.6,"evidence":"Disease match: parkinson's disease"},{"source_artifact_id":"wiki-entities-snca","link_type":"mentions","strength":0.8,"evidence":"Gene target: SNCA"},{"source_artifact_id":"wiki-cell-types-microglia","link_type":"mentions","strength":0.6,"evidence":"Title match: Microglia"},{"source_artifact_id":"wiki-diseases-snca-variants","link_type":"mentions","strength":0.8,"evidence":"Gene target: SNCA"},{"source_artifact_id":"wiki-proteins-snca-protein","link_type":"mentions","strength":0.8,"evidence":"Gene target: SNCA"},{"source_artifact_id":"wiki-diseases-dementia-lewy-bodies-parkinsons-alzheimers-comparison","link_type":"mentions","strength":0.6,"evidence":"Disease match: parkinson's disease"},{"source_artifact_id":"wiki-cell-types-snca-overexpressing-dopaminergic-neurons","link_type":"mentions","strength":0.8,"evidence":"Gene target: SNCA"},{"source_artifact_id":"wiki-diseases-investment-landscape-parkinsons","link_type":"mentions","strength":0.6,"evidence":"Disease match: parkinson's disease"},{"source_artifact_id":"wiki-diseases-alzheimers-parkinsons-comparison","link_type":"mentions","strength":0.6,"evidence":"Disease match: parkinson's disease"},{"source_artifact_id":"wiki-diseases-parkinsons-disease","link_type":"mentions","strength":0.6,"evidence":"Disease match: parkinson's disease"},{"source_artifact_id":"wiki-proteins-parkin","link_type":"mentions","strength":0.6,"evidence":"Title match: Parkin"},{"source_artifact_id":"wiki-entities-microglia","link_type":"mentions","strength":0.6,"evidence":"Title match: Microglia"},{"source_artifact_id":"wiki-mechanisms-snca-alpha-synuclein-pd-causal-chain","link_type":"mentions","strength":0.8,"evidence":"Gene target: SNCA"},{"source_artifact_id":"wiki-diseases-parkinsons-genetic-variants","link_type":"mentions","strength":0.6,"evidence":"Disease match: parkinson's disease"},{"source_artifact_id":"wiki-diseases-parkinsons-disease-dementia","link_type":"mentions","strength":0.6,"evidence":"Disease match: parkinson's disease"},{"source_artifact_id":"wiki-diseases-atp13a9-pd","link_type":"mentions","strength":0.6,"evidence":"Disease match: parkinson's disease"},{"source_artifact_id":"wiki-diseases-caregiver-support-palliative-care-cbs-psp","link_type":"mentions","strength":0.6,"evidence":"Disease match: parkinson's disease"},{"source_artifact_id":"wiki-diseases-parkinsons-disease","link_type":"related","strength":0.6,"evidence":"Disease match: Parkinson's disease"},{"source_artifact_id":"wiki-mechanisms-neuroinflammation","link_type":"related","strength":0.55,"evidence":"Pathway match: neuroinflammation, microglial activation"},{"source_artifact_id":"wiki-diseases","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 7x in wiki/diseases"},{"source_artifact_id":"wiki-datasets","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/datasets"},{"source_artifact_id":"wiki-ideas","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 3x in wiki/ideas"},{"source_artifact_id":"wiki-all-pages","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 4x in wiki/all-pages"},{"source_artifact_id":"wiki-therapeutics-neurorestore-therapies-pd","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 4x in wiki/therapeutics-neurorestore-therapies-pd"},{"source_artifact_id":"wiki-therapeutics-ad-pd-target-comparison-matrix","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/therapeutics-ad-pd-target-comparison-matrix"},{"source_artifact_id":"wiki-therapeutics-alpha-synuclein-aggregation-inhibitors","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 8x in wiki/therapeutics-alpha-synuclein-aggregation-inhibitors"},{"source_artifact_id":"wiki-therapeutics-combination-therapy","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/therapeutics-combination-therapy"},{"source_artifact_id":"wiki-therapeutics-nmn-nad-precursor-parkinsons","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 5x in wiki/therapeutics-nmn-nad-precursor-parkinsons"},{"source_artifact_id":"wiki-therapeutics-drug-targets","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 3x in wiki/therapeutics-drug-targets"},{"source_artifact_id":"wiki-therapeutics-section-107-crispr-therapies-cbs-psp","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 4x in wiki/therapeutics-section-107-crispr-therapies-cbs-psp"},{"source_artifact_id":"wiki-therapeutics-autophagy-enhancers-pd","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 4x in wiki/therapeutics-autophagy-enhancers-pd"},{"source_artifact_id":"wiki-therapeutics-inotersen-tegsedi","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 4x in wiki/therapeutics-inotersen-tegsedi"},{"source_artifact_id":"wiki-therapeutics-alpha-synuclein-targeting-therapies","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 9x in wiki/therapeutics-alpha-synuclein-targeting-therapies"},{"source_artifact_id":"wiki-therapeutics-synaptic-plasticity-therapeutics-pd","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 3x in wiki/therapeutics-synaptic-plasticity-therapeutics-pd"},{"source_artifact_id":"wiki-therapeutics-rna-targeting-therapy-neurodegeneration","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/therapeutics-rna-targeting-therapy-neurodegeneration"},{"source_artifact_id":"wiki-therapeutics-tissue-engineered-nigrostriatal-pathway","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 4x in wiki/therapeutics-tissue-engineered-nigrostriatal-pathway"},{"source_artifact_id":"wiki-therapeutics-aav-vectors-neurodegenerative-gene-therapy","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 6x in wiki/therapeutics-aav-vectors-neurodegenerative-gene-therapy"},{"source_artifact_id":"wiki-therapeutics-mrna-therapy-parkinsons","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 3x in wiki/therapeutics-mrna-therapy-parkinsons"},{"source_artifact_id":"wiki-therapeutics-retinoid-pathway-modulator-therapy-neurodegeneration","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/therapeutics-retinoid-pathway-modulator-therapy-neurodegeneration"},{"source_artifact_id":"wiki-therapeutics-crispr-gene-editing-parkinsons","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 16x in wiki/therapeutics-crispr-gene-editing-parkinsons"},{"source_artifact_id":"wiki-therapeutics-antisense-oligonucleotide-therapy","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/therapeutics-antisense-oligonucleotide-therapy"},{"source_artifact_id":"wiki-therapeutics-gene-editing-neurodegeneration","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/therapeutics-gene-editing-neurodegeneration"},{"source_artifact_id":"wiki-therapeutics-usp30-inhibitors","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 4x in wiki/therapeutics-usp30-inhibitors"},{"source_artifact_id":"wiki-therapeutics-mirna-therapy-parkinsons","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 11x in wiki/therapeutics-mirna-therapy-parkinsons"},{"source_artifact_id":"wiki-therapeutics-aso-tau-reduction","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/therapeutics-aso-tau-reduction"},{"source_artifact_id":"wiki-therapeutics-antisense-oligonucleotides-neurodegeneration","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/therapeutics-antisense-oligonucleotides-neurodegeneration"},{"source_artifact_id":"wiki-therapeutics-intranasal-therapy-parkinsons","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 4x in wiki/therapeutics-intranasal-therapy-parkinsons"},{"source_artifact_id":"wiki-therapeutics-antisense-oligonucleotide-therapy-neurodegeneration","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 4x in wiki/therapeutics-antisense-oligonucleotide-therapy-neurodegeneration"},{"source_artifact_id":"wiki-therapeutics-saa-guided-alpha-synuclein-therapy","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 5x in wiki/therapeutics-saa-guided-alpha-synuclein-therapy"},{"source_artifact_id":"wiki-therapeutics-bioactive-compound-autophagy-modulation","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 4x in wiki/therapeutics-bioactive-compound-autophagy-modulation"},{"source_artifact_id":"wiki-therapeutics-sirtuin-modulators-parkinsons","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 4x in wiki/therapeutics-sirtuin-modulators-parkinsons"},{"source_artifact_id":"wiki-therapeutics-sirna-therapy-parkinsons","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 13x in wiki/therapeutics-sirna-therapy-parkinsons"},{"source_artifact_id":"wiki-therapeutics-crispr-gene-editing","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 6x in wiki/therapeutics-crispr-gene-editing"},{"source_artifact_id":"wiki-therapeutics-levodopa-carbidopa-intestinal-gel","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/therapeutics-levodopa-carbidopa-intestinal-gel"},{"source_artifact_id":"wiki-therapeutics-alpha-synuclein-reduction-therapies","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 10x in wiki/therapeutics-alpha-synuclein-reduction-therapies"},{"source_artifact_id":"wiki-therapeutics-nlrp3-inhibitors-parkinsons","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 4x in wiki/therapeutics-nlrp3-inhibitors-parkinsons"},{"source_artifact_id":"wiki-therapeutics-neurodegeneration-therapeutic-target-comparison-matrix","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 8x in wiki/therapeutics-neurodegeneration-therapeutic-target-comparison-matrix"},{"source_artifact_id":"wiki-therapeutics-crispr-brain-delivery","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 4x in wiki/therapeutics-crispr-brain-delivery"},{"source_artifact_id":"wiki-therapeutics-alpha-synuclein-antisense-therapy","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 40x in wiki/therapeutics-alpha-synuclein-antisense-therapy"},{"source_artifact_id":"wiki-therapeutics-rna-targeting-therapies-neurodegeneration","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 7x in wiki/therapeutics-rna-targeting-therapies-neurodegeneration"},{"source_artifact_id":"wiki-therapeutics-pd-therapeutic-scorecard","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 4x in wiki/therapeutics-pd-therapeutic-scorecard"},{"source_artifact_id":"wiki-therapeutics-gba-gene-therapy-parkinsons","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 8x in wiki/therapeutics-gba-gene-therapy-parkinsons"},{"source_artifact_id":"wiki-therapeutics-buntanetap","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 5x in wiki/therapeutics-buntanetap"},{"source_artifact_id":"wiki-entities-tau-oligomers","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/entities-tau-oligomers"},{"source_artifact_id":"wiki-therapeutics-epigenetic-therapies-parkinsons","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 7x in wiki/therapeutics-epigenetic-therapies-parkinsons"},{"source_artifact_id":"wiki-therapeutics-cue1-device-pd","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/therapeutics-cue1-device-pd"},{"source_artifact_id":"wiki-therapeutics-gene-silencing-therapy","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 4x in wiki/therapeutics-gene-silencing-therapy"},{"source_artifact_id":"wiki-therapeutics-aso-brain-delivery","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 4x in wiki/therapeutics-aso-brain-delivery"},{"source_artifact_id":"wiki-therapeutics-antisense-therapy-neurodegeneration","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 4x in wiki/therapeutics-antisense-therapy-neurodegeneration"},{"source_artifact_id":"wiki-therapeutics-abbvie-brain-platform","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 4x in wiki/therapeutics-abbvie-brain-platform"},{"source_artifact_id":"wiki-therapeutics-alpha-synuclein-immunotherapy","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 7x in wiki/therapeutics-alpha-synuclein-immunotherapy"},{"source_artifact_id":"wiki-therapeutics-gba-gene-therapy","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 4x in wiki/therapeutics-gba-gene-therapy"},{"source_artifact_id":"wiki-therapeutics-epigenetic-therapies-parkinsons-disease","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 10x in wiki/therapeutics-epigenetic-therapies-parkinsons-disease"},{"source_artifact_id":"wiki-therapeutics-antisense-oligonucleotide-therapies","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/therapeutics-antisense-oligonucleotide-therapies"},{"source_artifact_id":"wiki-therapeutics-crispr-gene-editing-neurodegeneration","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 8x in wiki/therapeutics-crispr-gene-editing-neurodegeneration"},{"source_artifact_id":"wiki-therapeutics-therapeutic-targets","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/therapeutics-therapeutic-targets"},{"source_artifact_id":"wiki-therapeutics-circrna-dysfunction-restoration","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/therapeutics-circrna-dysfunction-restoration"},{"source_artifact_id":"wiki-therapeutics-adenosine-a2a-receptor-antagonists-pd","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/therapeutics-adenosine-a2a-receptor-antagonists-pd"},{"source_artifact_id":"wiki-therapeutics-aso-therapy-parkinsons","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 17x in wiki/therapeutics-aso-therapy-parkinsons"},{"source_artifact_id":"wiki-clinical-trials-aci-15916-parkinsons-pet-nct06891703","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/clinical-trials-aci-15916-parkinsons-pet-nct06891703"},{"source_artifact_id":"wiki-clinical-trials-ct1-dap001-ips-dopaminergic-progenitors-pd","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/clinical-trials-ct1-dap001-ips-dopaminergic-progenitors-pd"},{"source_artifact_id":"wiki-clinical-trials-nct05266417-nose-pd","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/clinical-trials-nct05266417-nose-pd"},{"source_artifact_id":"wiki-clinical-trials-apocynin-pd","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/clinical-trials-apocynin-pd"},{"source_artifact_id":"wiki-clinical-trials-nct06365190-rtms-pd","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 4x in wiki/clinical-trials-nct06365190-rtms-pd"},{"source_artifact_id":"wiki-clinical-trials-nct06954662-amino-acid-supplement-pd","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/clinical-trials-nct06954662-amino-acid-supplement-pd"},{"source_artifact_id":"wiki-clinical-trials-ab-1005-gdnf-gene-therapy-regenerate-pd","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/clinical-trials-ab-1005-gdnf-gene-therapy-regenerate-pd"},{"source_artifact_id":"wiki-clinical-trials-retigabine-pd","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/clinical-trials-retigabine-pd"},{"source_artifact_id":"wiki-clinical-trials-nct07308418-vibrotactile-stimulation-pd","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/clinical-trials-nct07308418-vibrotactile-stimulation-pd"},{"source_artifact_id":"wiki-clinical-trials-intranasal-insulin-glutathione-pd","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/clinical-trials-intranasal-insulin-glutathione-pd"},{"source_artifact_id":"wiki-clinical-trials-biib122-luma-lrrk2-inhibitor-pd","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/clinical-trials-biib122-luma-lrrk2-inhibitor-pd"},{"source_artifact_id":"wiki-clinical-trials-nct06687837-autologous-dopaminergic-neurons-pd","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/clinical-trials-nct06687837-autologous-dopaminergic-neurons-pd"},{"source_artifact_id":"wiki-clinical-trials-nct06821230-dyadic-mindfulness-pd","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/clinical-trials-nct06821230-dyadic-mindfulness-pd"},{"source_artifact_id":"wiki-clinical-trials-blaac-pd-nct06719583","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/clinical-trials-blaac-pd-nct06719583"},{"source_artifact_id":"wiki-clinical-trials-kenai-rndp001-pd-nct07106021","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 3x in wiki/clinical-trials-kenai-rndp001-pd-nct07106021"},{"source_artifact_id":"wiki-clinical-trials-valacyclovir-hsv1-pd","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/clinical-trials-valacyclovir-hsv1-pd"},{"source_artifact_id":"wiki-clinical-trials-mr-guided-focused-ultrasound-gcase-pd","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/clinical-trials-mr-guided-focused-ultrasound-gcase-pd"},{"source_artifact_id":"wiki-clinical-trials-upenn-neurodegenerative-disease-repository-nct04715399","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 3x in wiki/clinical-trials-upenn-neurodegenerative-disease-repository-nct04715399"},{"source_artifact_id":"wiki-clinical-trials-nct07174310","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/clinical-trials-nct07174310"},{"source_artifact_id":"wiki-clinical-trials-pde4-inhibitor-pd","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/clinical-trials-pde4-inhibitor-pd"},{"source_artifact_id":"wiki-clinical-trials-nouvneu001-pd","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/clinical-trials-nouvneu001-pd"},{"source_artifact_id":"wiki-clinical-trials-vibrotactile-coordinated-reset-pd","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/clinical-trials-vibrotactile-coordinated-reset-pd"},{"source_artifact_id":"wiki-clinical-trials-kp405-pd-nct06189170","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 4x in wiki/clinical-trials-kp405-pd-nct06189170"},{"source_artifact_id":"wiki-clinical-trials-coq10-qe3","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 3x in wiki/clinical-trials-coq10-qe3"},{"source_artifact_id":"wiki-clinical-trials-bacillus-subtilis-pd","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/clinical-trials-bacillus-subtilis-pd"},{"source_artifact_id":"wiki-hypotheses-oligodendrocyte-myelin-dysfunction-parkinsons","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 3x in wiki/hypotheses-oligodendrocyte-myelin-dysfunction-parkinsons"},{"source_artifact_id":"wiki-hypotheses-mlcs-dysfunction-parkinsons","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 7x in wiki/hypotheses-mlcs-dysfunction-parkinsons"},{"source_artifact_id":"wiki-hypotheses-ethnicity-specific-genetic-architecture-parkinsons","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 4x in wiki/hypotheses-ethnicity-specific-genetic-architecture-parkinsons"},{"source_artifact_id":"wiki-hypotheses-post-acute-viral-reservoir-parkinsons","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 4x in wiki/hypotheses-post-acute-viral-reservoir-parkinsons"},{"source_artifact_id":"wiki-hypotheses-extracellular-vesicle-synuclein-propagation-parkinsons","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 5x in wiki/hypotheses-extracellular-vesicle-synuclein-propagation-parkinsons"},{"source_artifact_id":"wiki-hypotheses-mitochondria-lysosome-contact-parkinsons","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 5x in wiki/hypotheses-mitochondria-lysosome-contact-parkinsons"},{"source_artifact_id":"wiki-hypotheses-peroxisomal-dysfunction-parkinsons","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/hypotheses-peroxisomal-dysfunction-parkinsons"},{"source_artifact_id":"wiki-hypotheses-glymphatic-circadian-axis-parkinsons","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/hypotheses-glymphatic-circadian-axis-parkinsons"},{"source_artifact_id":"wiki-hypotheses-hyp_885074","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 5x in wiki/hypotheses-hyp_885074"},{"source_artifact_id":"wiki-hypotheses-epigenetic-dysregulation-parkinsons","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 17x in wiki/hypotheses-epigenetic-dysregulation-parkinsons"},{"source_artifact_id":"wiki-hypotheses-hyp_332160","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 4x in wiki/hypotheses-hyp_332160"},{"source_artifact_id":"wiki-hypotheses-prion-vs-tau-alpha-syn-spread-comparison","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 4x in wiki/hypotheses-prion-vs-tau-alpha-syn-spread-comparison"},{"source_artifact_id":"wiki-hypotheses-hyp_575716","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 3x in wiki/hypotheses-hyp_575716"},{"source_artifact_id":"wiki-hypotheses-gap-junction-dysfunction-parkinsons","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 3x in wiki/hypotheses-gap-junction-dysfunction-parkinsons"},{"source_artifact_id":"wiki-hypotheses-cellular-senescence-parkinsons","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/hypotheses-cellular-senescence-parkinsons"},{"source_artifact_id":"wiki-hypotheses-purinergic-signaling-parkinsons","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/hypotheses-purinergic-signaling-parkinsons"},{"source_artifact_id":"wiki-datasets-amp-pd","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/datasets-amp-pd"},{"source_artifact_id":"wiki-circuits-parkinson-basal-ganglia-circuit","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 8x in wiki/circuits-parkinson-basal-ganglia-circuit"},{"source_artifact_id":"wiki-ideas-payload-aav-capsid-engineering-cns-therapy","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 4x in wiki/ideas-payload-aav-capsid-engineering-cns-therapy"},{"source_artifact_id":"wiki-ideas-payload-microglia-state-editing-trem2-lxr","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/ideas-payload-microglia-state-editing-trem2-lxr"},{"source_artifact_id":"wiki-ideas-delivery-microglia-targeted-nanoparticles","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/ideas-delivery-microglia-targeted-nanoparticles"},{"source_artifact_id":"wiki-ideas-novel-therapy-index","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 6x in wiki/ideas-novel-therapy-index"},{"source_artifact_id":"wiki-ideas-payload-aav-serotype-cns-delivery-optimization-therapy","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/ideas-payload-aav-serotype-cns-delivery-optimization-therapy"},{"source_artifact_id":"wiki-ideas-dlb-knowledge-gaps","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/ideas-dlb-knowledge-gaps"},{"source_artifact_id":"wiki-ideas-idea-tau-seed-interception","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/ideas-idea-tau-seed-interception"},{"source_artifact_id":"wiki-ideas-payload-msa-combo-therapy","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/ideas-payload-msa-combo-therapy"},{"source_artifact_id":"wiki-ideas-payload-mrna-intrabody-synuclein","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/ideas-payload-mrna-intrabody-synuclein"},{"source_artifact_id":"wiki-ideas-payload-msa-combination-therapy","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 3x in wiki/ideas-payload-msa-combination-therapy"},{"source_artifact_id":"wiki-ideas-circadian-entrainment-neuroprevention","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 4x in wiki/ideas-circadian-entrainment-neuroprevention"},{"source_artifact_id":"wiki-ideas-payload-crispri-snca-silencing","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 27x in wiki/ideas-payload-crispri-snca-silencing"},{"source_artifact_id":"wiki-ideas-payload-escrthost-iii-neuroprotection-therapy","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 4x in wiki/ideas-payload-escrthost-iii-neuroprotection-therapy"},{"source_artifact_id":"wiki-ideas-payload-rock-inhibitor-therapy","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/ideas-payload-rock-inhibitor-therapy"},{"source_artifact_id":"wiki-ideas-payload-aav-rna-targeting-neurodegeneration","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 4x in wiki/ideas-payload-aav-rna-targeting-neurodegeneration"},{"source_artifact_id":"wiki-ideas-prodromal-resilience-package","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/ideas-prodromal-resilience-package"},{"source_artifact_id":"wiki-investment-alpha-synuclein","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 4x in wiki/investment-alpha-synuclein"},{"source_artifact_id":"wiki-investment-rna-therapeutics-neurodegeneration","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 6x in wiki/investment-rna-therapeutics-neurodegeneration"},{"source_artifact_id":"wiki-investment-amyloid-therapeutics","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/investment-amyloid-therapeutics"},{"source_artifact_id":"wiki-cell-types-cerebellar-neurons-msa","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/cell-types-cerebellar-neurons-msa"},{"source_artifact_id":"wiki-cell-types-globus-pallidus-internus-pd","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/cell-types-globus-pallidus-internus-pd"},{"source_artifact_id":"wiki-cell-types-nigral-microglia-pd","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/cell-types-nigral-microglia-pd"},{"source_artifact_id":"wiki-cell-types-alpha-synuclein-expressing-neurons","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 6x in wiki/cell-types-alpha-synuclein-expressing-neurons"},{"source_artifact_id":"wiki-cell-types-dopaminergic-neurons-snpc","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/cell-types-dopaminergic-neurons-snpc"},{"source_artifact_id":"wiki-cell-types-ventral-tegmental-area-dopaminergic-neurons","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/cell-types-ventral-tegmental-area-dopaminergic-neurons"},{"source_artifact_id":"wiki-cell-types-iron-laden-microglia","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 3x in wiki/cell-types-iron-laden-microglia"},{"source_artifact_id":"wiki-cell-types-microglia-nasu-hakola","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 3x in wiki/cell-types-microglia-nasu-hakola"},{"source_artifact_id":"wiki-cell-types-dopaminergic-neurons","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/cell-types-dopaminergic-neurons"},{"source_artifact_id":"wiki-cell-types-alpha-syn-overexpressing","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 11x in wiki/cell-types-alpha-syn-overexpressing"},{"source_artifact_id":"wiki-cell-types-nigrostriatal-dopamine-terminals-pd","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/cell-types-nigrostriatal-dopamine-terminals-pd"},{"source_artifact_id":"wiki-cell-types-raphe-nuclei-mood","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/cell-types-raphe-nuclei-mood"},{"source_artifact_id":"wiki-cell-types-microglia-pd","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/cell-types-microglia-pd"},{"source_artifact_id":"wiki-cell-types-oligodendrocytes-msa","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 4x in wiki/cell-types-oligodendrocytes-msa"},{"source_artifact_id":"wiki-cell-types-alpha-synuclein-neurons","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 6x in wiki/cell-types-alpha-synuclein-neurons"},{"source_artifact_id":"wiki-cell-types-melanocytes-pd","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/cell-types-melanocytes-pd"},{"source_artifact_id":"wiki-cell-types-substantia-nigra-compacta","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 3x in wiki/cell-types-substantia-nigra-compacta"},{"source_artifact_id":"wiki-cell-types-alpha-synuclein-dopaminergic-neurons","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 3x in wiki/cell-types-alpha-synuclein-dopaminergic-neurons"},{"source_artifact_id":"wiki-cell-types-snc-dopamine-pd","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 3x in wiki/cell-types-snc-dopamine-pd"},{"source_artifact_id":"wiki-cell-types-amyloid-beta-exposed","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/cell-types-amyloid-beta-exposed"},{"source_artifact_id":"wiki-cell-types-microglia-batten-disease","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/cell-types-microglia-batten-disease"},{"source_artifact_id":"wiki-cell-types-amyloid-beta-cortical-neurons","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/cell-types-amyloid-beta-cortical-neurons"},{"source_artifact_id":"wiki-cell-types-substantia-nigra-pars-compacta-parkinsons","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/cell-types-substantia-nigra-pars-compacta-parkinsons"},{"source_artifact_id":"wiki-cell-types-alpha-synucleinopathy-neurons","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 4x in wiki/cell-types-alpha-synucleinopathy-neurons"},{"source_artifact_id":"wiki-cell-types-mitochondrial-dysfunction-dopaminergic-neurons","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/cell-types-mitochondrial-dysfunction-dopaminergic-neurons"},{"source_artifact_id":"wiki-cell-types-surveying-microglia","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 3x in wiki/cell-types-surveying-microglia"},{"source_artifact_id":"wiki-cell-types-dopamine-receptor-neurons","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 5x in wiki/cell-types-dopamine-receptor-neurons"},{"source_artifact_id":"wiki-cell-types-microglia-rasmussen","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/cell-types-microglia-rasmussen"},{"source_artifact_id":"wiki-cell-types-lipid-loaded-microglia","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 3x in wiki/cell-types-lipid-loaded-microglia"},{"source_artifact_id":"wiki-cell-types-dopaminergic-vta-pd","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/cell-types-dopaminergic-vta-pd"},{"source_artifact_id":"wiki-cell-types-disease-associated-microglia","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 3x in wiki/cell-types-disease-associated-microglia"},{"source_artifact_id":"wiki-cell-types-dorsal-raphe-serotonergic-neurons-pd","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 3x in wiki/cell-types-dorsal-raphe-serotonergic-neurons-pd"},{"source_artifact_id":"wiki-cell-types-vulnerable-dopaminergic-pd","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/cell-types-vulnerable-dopaminergic-pd"},{"source_artifact_id":"wiki-cell-types-microglia-states","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/cell-types-microglia-states"},{"source_artifact_id":"wiki-cell-types-microglia-synapse-pruning","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/cell-types-microglia-synapse-pruning"},{"source_artifact_id":"wiki-cell-types-m1-microglia","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 3x in wiki/cell-types-m1-microglia"},{"source_artifact_id":"wiki-cell-types-ca2-pyramidal-neurons","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/cell-types-ca2-pyramidal-neurons"},{"source_artifact_id":"wiki-cell-types-spinal-cord-microglia","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 3x in wiki/cell-types-spinal-cord-microglia"},{"source_artifact_id":"wiki-cell-types-enteric-neurons-alpha-syn","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/cell-types-enteric-neurons-alpha-syn"},{"source_artifact_id":"wiki-cell-types-amyloid-beta-exposed-neurons","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/cell-types-amyloid-beta-exposed-neurons"},{"source_artifact_id":"wiki-cell-types-aging-microglia","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 3x in wiki/cell-types-aging-microglia"},{"source_artifact_id":"wiki-cell-types-taupathology-astrocytes","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/cell-types-taupathology-astrocytes"},{"source_artifact_id":"wiki-cell-types-primed-microglia","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 3x in wiki/cell-types-primed-microglia"},{"source_artifact_id":"wiki-mechanisms-epigenetics-neurodegeneration","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 9x in wiki/mechanisms-epigenetics-neurodegeneration"},{"source_artifact_id":"wiki-mechanisms-substantia-nigra-selective-vulnerability-parkinsons","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/mechanisms-substantia-nigra-selective-vulnerability-parkinsons"},{"source_artifact_id":"wiki-mechanisms-pesticides-parkinson-pest-pd-nct06420310","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/mechanisms-pesticides-parkinson-pest-pd-nct06420310"},{"source_artifact_id":"wiki-mechanisms-atp13a2-lysosomal-pathway-parkinsons","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 4x in wiki/mechanisms-atp13a2-lysosomal-pathway-parkinsons"},{"source_artifact_id":"wiki-mechanisms-pd-alpha-synuclein-aggregation","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 10x in wiki/mechanisms-pd-alpha-synuclein-aggregation"},{"source_artifact_id":"wiki-mechanisms-dna-methylation-neurodegeneration","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/mechanisms-dna-methylation-neurodegeneration"},{"source_artifact_id":"wiki-mechanisms-pd-cure-roadmap","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 5x in wiki/mechanisms-pd-cure-roadmap"},{"source_artifact_id":"wiki-mechanisms-alpha-synuclein-seeding-kinetics","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 3x in wiki/mechanisms-alpha-synuclein-seeding-kinetics"},{"source_artifact_id":"wiki-mechanisms-rna-splicing","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 6x in wiki/mechanisms-rna-splicing"},{"source_artifact_id":"wiki-mechanisms-gwas-findings","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 7x in wiki/mechanisms-gwas-findings"},{"source_artifact_id":"wiki-mechanisms-protein-aggregation-seeds-neurodegeneration","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 4x in wiki/mechanisms-protein-aggregation-seeds-neurodegeneration"},{"source_artifact_id":"wiki-mechanisms-msa-pathophysiology-disease-mechanisms","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 3x in wiki/mechanisms-msa-pathophysiology-disease-mechanisms"},{"source_artifact_id":"wiki-mechanisms-gut-first-brain-first-alpha-synuclein-propagation","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/mechanisms-gut-first-brain-first-alpha-synuclein-propagation"},{"source_artifact_id":"wiki-mechanisms-rna-targeted-therapies-neurodegeneration","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 3x in wiki/mechanisms-rna-targeted-therapies-neurodegeneration"},{"source_artifact_id":"wiki-mechanisms-axonal-transport-pd-validation","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 4x in wiki/mechanisms-axonal-transport-pd-validation"},{"source_artifact_id":"wiki-mechanisms-prion-like-spread","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/mechanisms-prion-like-spread"},{"source_artifact_id":"wiki-mechanisms-nrf2-oxidative-stress","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/mechanisms-nrf2-oxidative-stress"},{"source_artifact_id":"wiki-mechanisms-transcription-regulation-neurodegeneration","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/mechanisms-transcription-regulation-neurodegeneration"},{"source_artifact_id":"wiki-mechanisms-membrane-driven-alpha-synuclein-nucleation","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 5x in wiki/mechanisms-membrane-driven-alpha-synuclein-nucleation"},{"source_artifact_id":"wiki-mechanisms-microrna-dysfunction","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/mechanisms-microrna-dysfunction"},{"source_artifact_id":"wiki-mechanisms-mtor-signaling-parkinsons","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 4x in wiki/mechanisms-mtor-signaling-parkinsons"},{"source_artifact_id":"wiki-mechanisms-macroautophagy-dysfunction-validation-pd","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/mechanisms-macroautophagy-dysfunction-validation-pd"},{"source_artifact_id":"wiki-mechanisms-amyloid-conformational-strains","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/mechanisms-amyloid-conformational-strains"},{"source_artifact_id":"wiki-mechanisms-epigenetic-regulation","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 6x in wiki/mechanisms-epigenetic-regulation"},{"source_artifact_id":"wiki-mechanisms-synuclein-pathway-parkinsons","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 16x in wiki/mechanisms-synuclein-pathway-parkinsons"},{"source_artifact_id":"wiki-mechanisms-mlcs-parkinsons-ipsc-methods","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 3x in wiki/mechanisms-mlcs-parkinsons-ipsc-methods"},{"source_artifact_id":"wiki-mechanisms-alpha-synuclein-oligomerization-pathways","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 6x in wiki/mechanisms-alpha-synuclein-oligomerization-pathways"},{"source_artifact_id":"wiki-mechanisms-cbs-psp-genetic-architecture","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/mechanisms-cbs-psp-genetic-architecture"},{"source_artifact_id":"wiki-mechanisms-protein-aggregation-comparison","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 3x in wiki/mechanisms-protein-aggregation-comparison"},{"source_artifact_id":"wiki-mechanisms-lewy-body-pathogenesis","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 3x in wiki/mechanisms-lewy-body-pathogenesis"},{"source_artifact_id":"wiki-mechanisms-dopaminergic-neurodegeneration","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/mechanisms-dopaminergic-neurodegeneration"},{"source_artifact_id":"wiki-mechanisms-multiple-system-atrophy-pathway","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/mechanisms-multiple-system-atrophy-pathway"},{"source_artifact_id":"wiki-mechanisms-synucleinopathies","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 12x in wiki/mechanisms-synucleinopathies"},{"source_artifact_id":"wiki-mechanisms-acly-alpha-synuclein-autophagy","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 4x in wiki/mechanisms-acly-alpha-synuclein-autophagy"},{"source_artifact_id":"wiki-mechanisms-dementia-lewy-bodies-pathway","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 7x in wiki/mechanisms-dementia-lewy-bodies-pathway"},{"source_artifact_id":"wiki-mechanisms-liquid-liquid-phase-separation","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 3x in wiki/mechanisms-liquid-liquid-phase-separation"},{"source_artifact_id":"wiki-mechanisms-alpha-synuclein-propagation-pathway","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 6x in wiki/mechanisms-alpha-synuclein-propagation-pathway"},{"source_artifact_id":"wiki-mechanisms-ad-pd-shared-pathways","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 7x in wiki/mechanisms-ad-pd-shared-pathways"},{"source_artifact_id":"wiki-mechanisms-amyloid-tau-synergistic-interaction-hypothesis","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/mechanisms-amyloid-tau-synergistic-interaction-hypothesis"},{"source_artifact_id":"wiki-mechanisms-rab39b-endosomal-lysosomal-pd-causal-chain","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 3x in wiki/mechanisms-rab39b-endosomal-lysosomal-pd-causal-chain"},{"source_artifact_id":"wiki-mechanisms-neuroresilience","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/mechanisms-neuroresilience"},{"source_artifact_id":"wiki-mechanisms-antisense-oligonucleotide-therapy-neurodegeneration","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/mechanisms-antisense-oligonucleotide-therapy-neurodegeneration"},{"source_artifact_id":"wiki-mechanisms-mptp-parkinson-model","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 5x in wiki/mechanisms-mptp-parkinson-model"},{"source_artifact_id":"wiki-mechanisms-synaptic-dysfunction-neurodegeneration","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 3x in wiki/mechanisms-synaptic-dysfunction-neurodegeneration"},{"source_artifact_id":"wiki-mechanisms-gsk3-parkinsons","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 3x in wiki/mechanisms-gsk3-parkinsons"},{"source_artifact_id":"wiki-mechanisms-gba-therapy-parkinsons","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/mechanisms-gba-therapy-parkinsons"},{"source_artifact_id":"wiki-mechanisms-convergent-pathways-neurodegeneration","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/mechanisms-convergent-pathways-neurodegeneration"},{"source_artifact_id":"wiki-mechanisms-amyloid-oligomers-neurodegeneration","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/mechanisms-amyloid-oligomers-neurodegeneration"},{"source_artifact_id":"wiki-mechanisms-gba-glucocerebrosidase-parkinsons","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 6x in wiki/mechanisms-gba-glucocerebrosidase-parkinsons"},{"source_artifact_id":"wiki-mechanisms-msa-animal-models-preclinical-research","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/mechanisms-msa-animal-models-preclinical-research"},{"source_artifact_id":"wiki-mechanisms-alpha-synuclein-aggregation-pathway","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 9x in wiki/mechanisms-alpha-synuclein-aggregation-pathway"},{"source_artifact_id":"wiki-mechanisms-gut-microbiome-lipid-parkinsons-axis","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/mechanisms-gut-microbiome-lipid-parkinsons-axis"},{"source_artifact_id":"wiki-mechanisms-gwas-findings-hub","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 6x in wiki/mechanisms-gwas-findings-hub"},{"source_artifact_id":"wiki-mechanisms-calcium-homeostasis-neurodegeneration","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 3x in wiki/mechanisms-calcium-homeostasis-neurodegeneration"},{"source_artifact_id":"wiki-mechanisms-calcium-dysregulation-neurodegeneration","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/mechanisms-calcium-dysregulation-neurodegeneration"},{"source_artifact_id":"wiki-mechanisms-alpha-synuclein-lrrk2-crosstalk","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 56x in wiki/mechanisms-alpha-synuclein-lrrk2-crosstalk"},{"source_artifact_id":"wiki-mechanisms-hippo-signaling-parkinsons-disease","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 3x in wiki/mechanisms-hippo-signaling-parkinsons-disease"},{"source_artifact_id":"wiki-mechanisms-mds-2026-pd-genetic-molecular-mechanisms","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 8x in wiki/mechanisms-mds-2026-pd-genetic-molecular-mechanisms"},{"source_artifact_id":"wiki-mechanisms-alpha-synuclein-clearance","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 7x in wiki/mechanisms-alpha-synuclein-clearance"},{"source_artifact_id":"wiki-mechanisms-pd-failed-approaches-analysis","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/mechanisms-pd-failed-approaches-analysis"},{"source_artifact_id":"wiki-mechanisms-polygenic-risk-scores-neurodegeneration","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/mechanisms-polygenic-risk-scores-neurodegeneration"},{"source_artifact_id":"wiki-mechanisms-msa-genetics-risk-factors","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 34x in wiki/mechanisms-msa-genetics-risk-factors"},{"source_artifact_id":"wiki-mechanisms-pd-genetic-penetrance","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 4x in wiki/mechanisms-pd-genetic-penetrance"},{"source_artifact_id":"wiki-mechanisms-alpha-synuclein-escrt-iii-inhibition","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 4x in wiki/mechanisms-alpha-synuclein-escrt-iii-inhibition"},{"source_artifact_id":"wiki-mechanisms-multi-omics-integration-neurodegeneration","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/mechanisms-multi-omics-integration-neurodegeneration"},{"source_artifact_id":"wiki-mechanisms-cerebellar-degeneration","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/mechanisms-cerebellar-degeneration"},{"source_artifact_id":"wiki-mechanisms-mlcs-quantification-pd","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 4x in wiki/mechanisms-mlcs-quantification-pd"},{"source_artifact_id":"wiki-mechanisms-circular-rna-dysfunction-neurodegeneration","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 3x in wiki/mechanisms-circular-rna-dysfunction-neurodegeneration"},{"source_artifact_id":"wiki-mechanisms-prime-editing-neurodegenerative-diseases","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 4x in wiki/mechanisms-prime-editing-neurodegenerative-diseases"},{"source_artifact_id":"wiki-mechanisms-protein-aggregation-disease-comparison","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 8x in wiki/mechanisms-protein-aggregation-disease-comparison"},{"source_artifact_id":"wiki-mechanisms-mlcs-parkinsons","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 3x in wiki/mechanisms-mlcs-parkinsons"},{"source_artifact_id":"wiki-mechanisms-metal-ion-synuclein-mitochondria-axis","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/mechanisms-metal-ion-synuclein-mitochondria-axis"},{"source_artifact_id":"wiki-mechanisms-mitochondria-lysosome-contact-parkinsons","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 3x in wiki/mechanisms-mitochondria-lysosome-contact-parkinsons"},{"source_artifact_id":"wiki-mechanisms-environmental-risk-factors","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/mechanisms-environmental-risk-factors"},{"source_artifact_id":"wiki-mechanisms-epigenetic-disease-comparison","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 6x in wiki/mechanisms-epigenetic-disease-comparison"},{"source_artifact_id":"wiki-mechanisms-alpha-synuclein-pathology","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 10x in wiki/mechanisms-alpha-synuclein-pathology"},{"source_artifact_id":"wiki-mechanisms-exosome-mediated-propagation","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 3x in wiki/mechanisms-exosome-mediated-propagation"},{"source_artifact_id":"wiki-mechanisms-mtdna-mutations-neurodegeneration","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/mechanisms-mtdna-mutations-neurodegeneration"},{"source_artifact_id":"wiki-mechanisms-er-stress-upr-parkinsons","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 3x in wiki/mechanisms-er-stress-upr-parkinsons"},{"source_artifact_id":"wiki-mechanisms-epigenetic-dysregulation-pathway","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 11x in wiki/mechanisms-epigenetic-dysregulation-pathway"},{"source_artifact_id":"wiki-mechanisms-membrane-trafficking-neurodegeneration","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 7x in wiki/mechanisms-membrane-trafficking-neurodegeneration"},{"source_artifact_id":"wiki-mechanisms-alpha-synuclein-propagation","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 14x in wiki/mechanisms-alpha-synuclein-propagation"},{"source_artifact_id":"wiki-mechanisms-cross-disease-convergence-investment-ranking","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/mechanisms-cross-disease-convergence-investment-ranking"},{"source_artifact_id":"wiki-mechanisms-epigenetic-clocks-brain-aging","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 3x in wiki/mechanisms-epigenetic-clocks-brain-aging"},{"source_artifact_id":"wiki-mechanisms-alpha-synuclein-transgenic-mouse","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 9x in wiki/mechanisms-alpha-synuclein-transgenic-mouse"},{"source_artifact_id":"wiki-mechanisms-lewy-body-formation","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 8x in wiki/mechanisms-lewy-body-formation"},{"source_artifact_id":"wiki-mechanisms-splice-modulation-neurodegeneration","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 4x in wiki/mechanisms-splice-modulation-neurodegeneration"},{"source_artifact_id":"wiki-mechanisms-therapeutic-development-failure-mode-analysis-synthesis","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/mechanisms-therapeutic-development-failure-mode-analysis-synthesis"},{"source_artifact_id":"wiki-mechanisms-dopamine-pathway","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/mechanisms-dopamine-pathway"},{"source_artifact_id":"wiki-mechanisms-pd-synaptic-vesicle-trafficking-pathway","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 6x in wiki/mechanisms-pd-synaptic-vesicle-trafficking-pathway"},{"source_artifact_id":"wiki-mechanisms-alpha-synuclein","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 5x in wiki/mechanisms-alpha-synuclein"},{"source_artifact_id":"wiki-mechanisms-msa-treatment-approaches-emerging-therapies","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 3x in wiki/mechanisms-msa-treatment-approaches-emerging-therapies"},{"source_artifact_id":"wiki-mechanisms-jak-stat-signaling-pathway-neurodegeneration","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 4x in wiki/mechanisms-jak-stat-signaling-pathway-neurodegeneration"},{"source_artifact_id":"wiki-mechanisms-lewy-body-formation-pathway","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 3x in wiki/mechanisms-lewy-body-formation-pathway"},{"source_artifact_id":"wiki-mechanisms-rna-therapeutics-investment-synthesis","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 11x in wiki/mechanisms-rna-therapeutics-investment-synthesis"},{"source_artifact_id":"wiki-mechanisms-lrrk2-signaling-pathway","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 3x in wiki/mechanisms-lrrk2-signaling-pathway"},{"source_artifact_id":"wiki-mechanisms-kinase-targeting-neurodegenerative-diseases","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/mechanisms-kinase-targeting-neurodegenerative-diseases"},{"source_artifact_id":"wiki-mechanisms-mirna-regulation-neurodegeneration","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/mechanisms-mirna-regulation-neurodegeneration"},{"source_artifact_id":"wiki-mechanisms-gba-lysosomal-function-parkinsons","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 3x in wiki/mechanisms-gba-lysosomal-function-parkinsons"},{"source_artifact_id":"wiki-mechanisms-msa-cure-roadmap","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 7x in wiki/mechanisms-msa-cure-roadmap"},{"source_artifact_id":"wiki-mechanisms-selective-neuronal-vulnerability","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/mechanisms-selective-neuronal-vulnerability"},{"source_artifact_id":"wiki-mechanisms-4r-tauopathy-tau-proteostasis","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/mechanisms-4r-tauopathy-tau-proteostasis"},{"source_artifact_id":"wiki-mechanisms-nct04724941-prodromal-alpha-synuclein-screening","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 5x in wiki/mechanisms-nct04724941-prodromal-alpha-synuclein-screening"},{"source_artifact_id":"wiki-mechanisms-oxidative-stress-comparison","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 7x in wiki/mechanisms-oxidative-stress-comparison"},{"source_artifact_id":"wiki-mechanisms-extracellular-vesicles-parkinsons","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 4x in wiki/mechanisms-extracellular-vesicles-parkinsons"},{"source_artifact_id":"wiki-mechanisms-rna-splicing-defects","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 5x in wiki/mechanisms-rna-splicing-defects"},{"source_artifact_id":"wiki-mechanisms-autophagy-lysosome-neurodegeneration","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/mechanisms-autophagy-lysosome-neurodegeneration"},{"source_artifact_id":"wiki-mechanisms-non-dopaminergic-neurotransmitter-degeneration-parkinsons","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 3x in wiki/mechanisms-non-dopaminergic-neurotransmitter-degeneration-parkinsons"},{"source_artifact_id":"wiki-mechanisms-disease-mechanism-taxonomy","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/mechanisms-disease-mechanism-taxonomy"},{"source_artifact_id":"wiki-mechanisms-protein-trafficking-pathways","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 3x in wiki/mechanisms-protein-trafficking-pathways"},{"source_artifact_id":"wiki-mechanisms-glial-cytoplasmic-inclusions-msa","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/mechanisms-glial-cytoplasmic-inclusions-msa"},{"source_artifact_id":"wiki-mechanisms-parkinsons-disease-mechanisms","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 3x in wiki/mechanisms-parkinsons-disease-mechanisms"},{"source_artifact_id":"wiki-mechanisms-lactate-lactylation-neurodegeneration","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 3x in wiki/mechanisms-lactate-lactylation-neurodegeneration"},{"source_artifact_id":"wiki-mechanisms-network-pharmacology-neurodegeneration-synthesis","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/mechanisms-network-pharmacology-neurodegeneration-synthesis"},{"source_artifact_id":"wiki-mechanisms-synucleinopathy","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 17x in wiki/mechanisms-synucleinopathy"},{"source_artifact_id":"wiki-mechanisms-gba1-gcase-lysosome-pd-causal-chain","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 4x in wiki/mechanisms-gba1-gcase-lysosome-pd-causal-chain"},{"source_artifact_id":"wiki-mechanisms-epigenetics-parkinsons","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 18x in wiki/mechanisms-epigenetics-parkinsons"},{"source_artifact_id":"wiki-mechanisms-alpha-synuclein-prion-like-spreading","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 8x in wiki/mechanisms-alpha-synuclein-prion-like-spreading"},{"source_artifact_id":"wiki-mechanisms-alpha-synuclein-propagation-mechanisms","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/mechanisms-alpha-synuclein-propagation-mechanisms"},{"source_artifact_id":"wiki-mechanisms-protein-protein-interactions-neurodegeneration","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 4x in wiki/mechanisms-protein-protein-interactions-neurodegeneration"},{"source_artifact_id":"wiki-mechanisms-alpha-synuclein-aggregation","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 12x in wiki/mechanisms-alpha-synuclein-aggregation"},{"source_artifact_id":"wiki-mechanisms-glial-neuron-crosstalk-parkinsons","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/mechanisms-glial-neuron-crosstalk-parkinsons"},{"source_artifact_id":"wiki-mechanisms-epigenetic-dysregulation-comparison","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 16x in wiki/mechanisms-epigenetic-dysregulation-comparison"},{"source_artifact_id":"wiki-mechanisms-biomarkers-neurodegeneration","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/mechanisms-biomarkers-neurodegeneration"},{"source_artifact_id":"wiki-mechanisms-alpha-synuclein-exosomal-secretion","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 4x in wiki/mechanisms-alpha-synuclein-exosomal-secretion"},{"source_artifact_id":"wiki-mechanisms-biomarkers-parkinsons","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 6x in wiki/mechanisms-biomarkers-parkinsons"},{"source_artifact_id":"wiki-mechanisms-rna-g-quadruplexes-neurodegeneration","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 4x in wiki/mechanisms-rna-g-quadruplexes-neurodegeneration"},{"source_artifact_id":"wiki-mechanisms-multi-ethnic-pd-gwas","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 9x in wiki/mechanisms-multi-ethnic-pd-gwas"},{"source_artifact_id":"wiki-mechanisms-dopamine-signaling","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 3x in wiki/mechanisms-dopamine-signaling"},{"source_artifact_id":"wiki-mechanisms-msa-alpha-synuclein-glial-cytoplasmic-inclusions","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 16x in wiki/mechanisms-msa-alpha-synuclein-glial-cytoplasmic-inclusions"},{"source_artifact_id":"wiki-mechanisms-epigenetic-dysregulation-neurodegeneration","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 3x in wiki/mechanisms-epigenetic-dysregulation-neurodegeneration"},{"source_artifact_id":"wiki-mechanisms-precision-medicine-neurodegeneration","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/mechanisms-precision-medicine-neurodegeneration"},{"source_artifact_id":"wiki-mechanisms-lncrna-signaling-neurodegeneration","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/mechanisms-lncrna-signaling-neurodegeneration"},{"source_artifact_id":"wiki-mechanisms-astrocyte-metabolic-enhancement-pd","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 4x in wiki/mechanisms-astrocyte-metabolic-enhancement-pd"},{"source_artifact_id":"wiki-mechanisms-alpha-synuclein-prodromal-propagation","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 5x in wiki/mechanisms-alpha-synuclein-prodromal-propagation"},{"source_artifact_id":"wiki-projects-what-to-work-on","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/projects-what-to-work-on"},{"source_artifact_id":"wiki-technologies-digital-therapeutics-pd","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 4x in wiki/technologies-digital-therapeutics-pd"},{"source_artifact_id":"wiki-technologies-digital-biomarkers-pd","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/technologies-digital-biomarkers-pd"},{"source_artifact_id":"wiki-technologies-wearable-sensors-pd","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/technologies-wearable-sensors-pd"},{"source_artifact_id":"wiki-technologies-crispr-gene-editing","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 3x in wiki/technologies-crispr-gene-editing"},{"source_artifact_id":"wiki-technologies-alphafold","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/technologies-alphafold"},{"source_artifact_id":"wiki-technologies-ai-movement-analysis-pd","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/technologies-ai-movement-analysis-pd"},{"source_artifact_id":"wiki-technologies-crispr-gene-editing-neurodegeneration","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 4x in wiki/technologies-crispr-gene-editing-neurodegeneration"},{"source_artifact_id":"wiki-models-a30p-alpha-synuclein-mouse-model","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/models-a30p-alpha-synuclein-mouse-model"},{"source_artifact_id":"wiki-biomarkers-phosphorylated-alpha-synuclein-pser129","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/biomarkers-phosphorylated-alpha-synuclein-pser129"},{"source_artifact_id":"wiki-biomarkers-parkinsons-disease-biomarkers","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/biomarkers-parkinsons-disease-biomarkers"},{"source_artifact_id":"wiki-biomarkers-total-tau-t-tau","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/biomarkers-total-tau-t-tau"},{"source_artifact_id":"wiki-biomarkers-mds-2026-genetics-biomarkers-movement-disorders","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 5x in wiki/biomarkers-mds-2026-genetics-biomarkers-movement-disorders"},{"source_artifact_id":"wiki-biomarkers-alpha-synuclein-seed-amplification","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 3x in wiki/biomarkers-alpha-synuclein-seed-amplification"},{"source_artifact_id":"wiki-biomarkers-amyloid-beta-40-abeta-40","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/biomarkers-amyloid-beta-40-abeta-40"},{"source_artifact_id":"wiki-biomarkers-multiple-system-atrophy-biomarkers","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/biomarkers-multiple-system-atrophy-biomarkers"},{"source_artifact_id":"wiki-biomarkers-alpha-synuclein-oligomers","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/biomarkers-alpha-synuclein-oligomers"},{"source_artifact_id":"wiki-biomarkers-alpha-synuclein","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 4x in wiki/biomarkers-alpha-synuclein"},{"source_artifact_id":"wiki-biomarkers-adpd-2026-precision-medicine-genetic-stratification","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 10x in wiki/biomarkers-adpd-2026-precision-medicine-genetic-stratification"},{"source_artifact_id":"wiki-biomarkers-alpha-synuclein-seed-kinetics-pd","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 7x in wiki/biomarkers-alpha-synuclein-seed-kinetics-pd"},{"source_artifact_id":"wiki-biomarkers-epigenetic-biomarkers-neurodegeneration","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 3x in wiki/biomarkers-epigenetic-biomarkers-neurodegeneration"},{"source_artifact_id":"wiki-events-mds-2026-neuroprotection-neurorestorative-parkinsons","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/events-mds-2026-neuroprotection-neurorestorative-parkinsons"},{"source_artifact_id":"wiki-entities-microglia-in-neurodegeneration","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 3x in wiki/entities-microglia-in-neurodegeneration"},{"source_artifact_id":"wiki-entities-ub-312","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 3x in wiki/entities-ub-312"},{"source_artifact_id":"wiki-entities-nucleus-basalis-meynert","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 3x in wiki/entities-nucleus-basalis-meynert"},{"source_artifact_id":"wiki-entities-amyloid-pet","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/entities-amyloid-pet"},{"source_artifact_id":"wiki-entities-tau-pet","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/entities-tau-pet"},{"source_artifact_id":"wiki-entities-dna-methylation","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/entities-dna-methylation"},{"source_artifact_id":"wiki-entities-aria-imaging","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/entities-aria-imaging"},{"source_artifact_id":"wiki-entities-overview","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 4x in wiki/entities-overview"},{"source_artifact_id":"wiki-brain-regions-striatum","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 3x in wiki/brain-regions-striatum"},{"source_artifact_id":"wiki-brain-regions-substantia-nigra","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 6x in wiki/brain-regions-substantia-nigra"},{"source_artifact_id":"wiki-experiments-oligodendrocyte-myelin-dysfunction-parkinsons","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/experiments-oligodendrocyte-myelin-dysfunction-parkinsons"},{"source_artifact_id":"wiki-experiments-alpha-synuclein-aggregation-triggers-sporadic-pd","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/experiments-alpha-synuclein-aggregation-triggers-sporadic-pd"},{"source_artifact_id":"wiki-experiments-dlb-tau-copathology","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/experiments-dlb-tau-copathology"},{"source_artifact_id":"wiki-experiments-glp1-responder-prediction-pd","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 3x in wiki/experiments-glp1-responder-prediction-pd"},{"source_artifact_id":"wiki-experiments-alpha-syn-saa-kinetics-pd","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/experiments-alpha-syn-saa-kinetics-pd"},{"source_artifact_id":"wiki-experiments-pd-disease-subtype-classification","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/experiments-pd-disease-subtype-classification"},{"source_artifact_id":"wiki-experiments-synaptic-mitochondrial-resilience-pd","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/experiments-synaptic-mitochondrial-resilience-pd"},{"source_artifact_id":"wiki-experiments-glymphatic-circadian-axis-parkinsons","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 3x in wiki/experiments-glymphatic-circadian-axis-parkinsons"},{"source_artifact_id":"wiki-experiments-alpha-synuclein-spreading-neurodegeneration-pd","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 4x in wiki/experiments-alpha-synuclein-spreading-neurodegeneration-pd"},{"source_artifact_id":"wiki-experiments-epigenetic-dysregulation-parkinsons","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 7x in wiki/experiments-epigenetic-dysregulation-parkinsons"},{"source_artifact_id":"wiki-experiments-combination-therapy-sequencing-pd","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/experiments-combination-therapy-sequencing-pd"},{"source_artifact_id":"wiki-experiments-membrane-nucleation-ipsc-validation","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/experiments-membrane-nucleation-ipsc-validation"},{"source_artifact_id":"wiki-experiments-multi-ethnic-pd-gwas","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/experiments-multi-ethnic-pd-gwas"},{"source_artifact_id":"wiki-experiments-dlb-genetic-modifiers","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 5x in wiki/experiments-dlb-genetic-modifiers"},{"source_artifact_id":"wiki-experiments-dopaminergic-neuron-selective-vulnerability-pd","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/experiments-dopaminergic-neuron-selective-vulnerability-pd"},{"source_artifact_id":"wiki-experiments-toxin-microbiome-parkinsons","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/experiments-toxin-microbiome-parkinsons"},{"source_artifact_id":"wiki-organizations-denali-therapeutics","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 6x in wiki/organizations-denali-therapeutics"},{"source_artifact_id":"wiki-organizations-tau-consortium","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/organizations-tau-consortium"},{"source_artifact_id":"wiki-diseases-msa","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/diseases-msa"},{"source_artifact_id":"wiki-diseases-pure-autonomic-failure","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/diseases-pure-autonomic-failure"},{"source_artifact_id":"wiki-diseases-lrrk2-g2019s","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/diseases-lrrk2-g2019s"},{"source_artifact_id":"wiki-diseases-dementia-with-lewy-bodies","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 4x in wiki/diseases-dementia-with-lewy-bodies"},{"source_artifact_id":"wiki-diseases-mds-2026-genetic-pd","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/diseases-mds-2026-genetic-pd"},{"source_artifact_id":"wiki-diseases-parkinson-disease","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 3x in wiki/diseases-parkinson-disease"},{"source_artifact_id":"wiki-diseases-multiple-system-atrophy","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 7x in wiki/diseases-multiple-system-atrophy"},{"source_artifact_id":"wiki-diseases-atypical-parkinsonism-genetic-variants","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 5x in wiki/diseases-atypical-parkinsonism-genetic-variants"},{"source_artifact_id":"wiki-diseases-alpha-synucleinopathies-comparison","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 7x in wiki/diseases-alpha-synucleinopathies-comparison"},{"source_artifact_id":"wiki-diseases-alpha-synucleinopathies","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 6x in wiki/diseases-alpha-synucleinopathies"},{"source_artifact_id":"wiki-diseases-msa-genetic-variants","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 23x in wiki/diseases-msa-genetic-variants"},{"source_artifact_id":"wiki-diseases-familial-vs-sporadic-neurodegeneration","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 7x in wiki/diseases-familial-vs-sporadic-neurodegeneration"},{"source_artifact_id":"wiki-diseases-neurodegeneration","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 3x in wiki/diseases-neurodegeneration"},{"source_artifact_id":"wiki-diseases-familial-sporadic-neurodegeneration","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 3x in wiki/diseases-familial-sporadic-neurodegeneration"},{"source_artifact_id":"wiki-diseases-mitochondrial-neurodegeneration-comparison","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/diseases-mitochondrial-neurodegeneration-comparison"},{"source_artifact_id":"wiki-diseases-disease-classification","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/diseases-disease-classification"},{"source_artifact_id":"wiki-diseases-dementia-lewy-bodies","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 3x in wiki/diseases-dementia-lewy-bodies"},{"source_artifact_id":"wiki-diseases-sporadic-familial-pd-comparison","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 21x in wiki/diseases-sporadic-familial-pd-comparison"},{"source_artifact_id":"wiki-diseases-rem-sleep-behavior-disorder","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 3x in wiki/diseases-rem-sleep-behavior-disorder"},{"source_artifact_id":"wiki-diseases-lewy-body-dementia","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 4x in wiki/diseases-lewy-body-dementia"},{"source_artifact_id":"wiki-cell-types-gustatory-taste-receptor-neurons","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/cell-types-gustatory-taste-receptor-neurons"},{"source_artifact_id":"wiki-cell-types-rotenone-exposed-dopaminergic-neurons","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/cell-types-rotenone-exposed-dopaminergic-neurons"},{"source_artifact_id":"wiki-cell-types-synucleinopathy-neurons","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/cell-types-synucleinopathy-neurons"},{"source_artifact_id":"wiki-cell-types-photoreceptor-cells-parkinsons-disease","link_type":"mentions","strength":0.5,"evidence":"Content: SNCA mentioned 3x in wiki/cell-types-photoreceptor-cells-parkinsons-disease"},{"source_artifact_id":"wiki-cell-types-pedunculopontine-nucleus-cholinergic-neurons-in-lewy-body-disease","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/cell-types-pedunculopontine-nucleus-cholinergic-neurons-in-lewy-body-disease"},{"source_artifact_id":"wiki-cell-types-autonomic-neurons-multiple-system-atrophy","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SNCA mentioned 2x in wiki/cell-types-autonomic-neurons-multiple-system-atrophy"},{"source_artifact_id":"wiki-depression","link_type":"related","strength":0.7,"evidence":"disease: Parkinson's disease"}],"current_artifact_id":"experiment-exp-cd85e950-e169-432f-a651-510fdde03f01","is_canonical":true,"supersede_chain":["experiment-exp-cd85e950-e169-432f-a651-510fdde03f01"]}